Phase III results in local and regional lung cancer
Phase III results in local and regional lung can
Interview: “These findings will change the standard-of-care”
Interview: “These findings will change the stand
Further analyses of biomarkers
Further analyses of biomarkers Immune checkp
Novel approaches in small-cell lung cancer
Novel approaches in small-cell lung cancer S
Statement: “Select the patients who will be able to benefit”
Statement: “Select the patients who will be able
Immunotherapy: effective treatments gathering on the horizon
Immunotherapy: effective treatments gathering on
Interview: “EGFR testing is a reality in European countries”
Interview: “EGFR testing is a reality in Europea
Metastatic NSCLC: new drugs and updates in well-known agents
Metastatic NSCLC: new drugs and updates in well-
Preface – ASCO 2015
Preface – ASCO 2015 Dear Colleagues, As for
